Viewing Study NCT03702894


Ignite Creation Date: 2025-12-25 @ 1:44 AM
Ignite Modification Date: 2026-03-05 @ 6:03 PM
Study NCT ID: NCT03702894
Status: COMPLETED
Last Update Posted: 2019-05-14
First Post: 2018-10-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Bioequivalence Study of Clavamox, Film-coated Tablets, 875 mg + 125 mg Pharmtechnology LLC, Belarus), and Augmentin®, Film-coated Tablets, 875 mg + 125 mg (GlaxoSmithKline Trading CJSC, Russia), in Healthy Volunteers Under Fasting Conditions
Sponsor: Pharmtechnology LLC
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Bioequivalence View
Keywords:

Keywords

Keyword Brief Keyword Text View
None bioequivalence View
None amoxicillin View
None clavulanic acid View
None Augmentin View